India’s medical system has many flaws but then it has its merits too. Indian generic drug makers have helped many medicines become affordable to the masses. A success story you should read about.
Low drug prices come about only if certain conditions are cultivated. Creating those conditions means tackling both intellectual property barriers and regulatory barriers, both of which happened in India. While Indian generics makers were trying to develop their own version of the drug, advocacy groups — and even some Indian generics makers — were challenging Gilead’s patent claims in Indian court. At the same time, patient groups approached Indian regulators to fast track approval of the drug for sale in the country. It also helped that there was already a public health program in place which would directly stand to benefit if sofosbuvir was approved.
Needull in a haystack 